2023 GOLD International COPD Conference
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs
Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Listen it here.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
El pasado mes de febrero la UB celebró en su sala Paraninfo La “Barcelona Boston Lung Conference”, un foro anual de debate científico al más alto nivel sobre diversos aspectos de las enfermedades respiratorias, con un elenco de ponentes del máximo nivel internacional.
Àlvar Agustí ha participado en este evento como miembro del comité científico de la reunión, resaltando la importancia de “pasar de una medicina reactiva a una medicina predictiva…»
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively.